SPC291
Rómósósúmab
Status:
VeittApplication date:
16.3.2020Application published:
15.4.2020Grant published:
15.11.2020
Max expiry date:
27.4.2031Next due date:
30.4.2026Medicine name:
EvenityMedicine for children:
No
Timeline
Today
16.3.2020Application
15.4.2020Publication
15.11.2020Registration
27.4.2031Expires
Marketing license
IS authorization number:
EU/1/19/1411/001-004Date:
12.12.2019
Foreign authorization number:
EU/1/19/1411Date:
9.12.2019
Owner
Name:
AMGEN, INC.Address:
One Amgen Center Drive, Thousand Oaks, CA US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1891101